Literature DB >> 8118610

Neoplastic transformation and characterization of human fibroblasts by treatment with 60Co gamma rays and the human c-Ha-ras oncogene.

I Jahan1, K Mihara, L Bai, M Namba.   

Abstract

Human fibroblasts (KMST-6) immortalized by treatment with 60Co gamma rays were further neoplastically transformed by transfection of the c-Ha-ras oncogene from human lung cancer. The ras-transfected cells formed undifferentiated fibrosarcoma in nude mice. One of the tumors was recultured and a neoplastic human fibroblast line, KMST-6/RAS, was established. To analyze multistep carcinogenesis of human cells, the cellular characteristics of these genetically matched immortalized (KMST-6) and neoplastic (KMST-6/RAS) cell lines were studied in detail. KMST-6/RAS cells showed an increased saturation density, colony formation on confluent monolayers of normal human fibroblasts, proliferation in neomycin-containing medium, anchorage-independent growth, and enhanced expression of the transfected c-Ha-ras oncogene, whereas the immortalized cells did not demonstrate these characteristics. Unexpectedly, growth of KMST-6/RAS cells was serum-dependent, although they were neoplastic. Interestingly, the neoplastic cells did not show the criss-crossing or piling up growth pattern characteristic of transformed rodent fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8118610     DOI: 10.1007/bf02634342

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  24 in total

1.  Malignant transformation of human fibroblasts previously immortalized with 60Co gamma rays.

Authors:  K Mihara; L Bai; Y Kano; M Miyazaki; M Namba
Journal:  Int J Cancer       Date:  1992-02-20       Impact factor: 7.396

2.  Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene.

Authors:  P J Hurlin; V M Maher; J J McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Evidence for the multistep nature of in vitro human epithelial cell carcinogenesis.

Authors:  J S Rhim; J H Yoo; J H Park; P Thraves; Z Salehi; A Dritschilo
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

4.  Usage of vertebrate, invertebrate and plant cell, tissue and organ culture terminology.

Authors:  W I Schaeffer
Journal:  In Vitro       Date:  1984-01

5.  Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.

Authors:  Y Yuasa; S K Srivastava; C Y Dunn; J S Rhim; E P Reddy; S A Aaronson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

6.  Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1.

Authors:  B I Gerwin; E Spillare; K Forrester; T A Lehman; J Kispert; J A Welsh; A M Pfeifer; J F Lechner; S J Baker; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Malignant transformation of human fibroblasts by a transfected N-ras oncogene.

Authors:  D M Wilson; D J Yang; J E Dillberger; S E Dietrich; V M Maher; J J McCormick
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

8.  Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.

Authors:  A M Pfeifer; R T Jones; P E Bowden; D Mann; E Spillare; A J Klein-Szanto; B F Trump; C C Harris
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

9.  Separation of immortalization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product.

Authors:  R Freund; R T Bronson; T L Benjamin
Journal:  Oncogene       Date:  1992-10       Impact factor: 9.867

10.  The biology of human cells in tissue culture. I. Characterization of cells derived from osteogenic sarcomas.

Authors:  H S Smith; R B Owens; A J Hiller; W A Nelson-Rees; J O Johnston
Journal:  Int J Cancer       Date:  1976-02-15       Impact factor: 7.396

View more
  6 in total

1.  Telomere elongation observed in immortalized human fibroblasts by treatment with 60Co gamma rays or 4-nitroquinoline 1-oxide.

Authors:  S Sugihara; K Mihara; T Marunouchi; H Inoue; M Namba
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

2.  Development of a serum-free medium for a human immortalized fibroblast cell line (KMST-6/TNF) producing tumor necrosis factor-alpha (TNF-alpha) and growth inhibitory effects of its conditioned medium on malignant cells in culture.

Authors:  S H Oh; M Miyazaki; M Namba
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-03       Impact factor: 2.416

3.  p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.

Authors:  J Westermarck; S P Li; T Kallunki; J Han; V M Kähäri
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

4.  Effects of okadaic acid on cell growth, anchorage-independent growth, and co-cultures of normal (KMS-6), immortalized (KMST-6), and neoplastically transformed (KMST-6T and KMST-6/RAS) human fibroblasts.

Authors:  I Jahan; M Iijima; T Kondo; M Namba
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Granulocyte-colony stimulating factor (G-CSF) production of human fibroblasts (KMST-6/RAS line) transformed with 60Co gamma rays and c-Ha-ras oncogene.

Authors:  K Kawashima; M Mori; S Furusako; H Usuki; N Shimizu; M Namba
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-04       Impact factor: 2.416

6.  Establishment of a human fibroblast cell line producing tumor necrosis factor alpha (KMST-6/TNF) and growth inhibitory effects of its conditioned medium on malignant cells in culture.

Authors:  K Fushimi; K Torigoe; H Yamauchi; S Furusako; M Kurimoto; M Namba
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-06       Impact factor: 2.723

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.